Elon Musk's controversial biotech startup Neuralink has obtained authorisation to start recruiting for its first human trials.
"We are happy to announce that we've received approval from the reviewing independent institutional review board and our first hospital site to begin recruitment for our first-in-human clinical tri...
To continue reading this article...
Join Computing
- Unlimited access to real-time news, analysis and opinion from the technology industry
- Receive important and breaking news in our daily newsletter
- Be the first to hear about our events and awards programmes
- Join live member only interviews with IT leaders at the ‘IT Lounge’; your chance to ask your burning tech questions and have them answered
- Access to the Computing Delta hub providing market intelligence and research
- Receive our members-only newsletter with exclusive opinion pieces from senior IT Leaders